Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, September 12, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Debjit Chattopadhyay Initiated (BNTC) at Strong Buy and Held Target at $17 on, Sep 12th, 2024
Published on 2024-10-28 14:12:51 - WOPRAI, Debjit Chattopadhyay
Debjit Chattopadhyay of Guggenheim, Initiated "Benitec Biopharma Inc." (BNTC) at Strong Buy and Held Target at $17 on, Sep 12th, 2024.
Debjit has made no other calls on BNTC in the last 4 months.
There are 2 other peers that have a rating on BNTC. Out of the 2 peers that are also analyzing BNTC, 0 agree with Debjit's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Debjit
- Mani Foroohar of "Leerink Partners" Initiated at Buy and Held Target at $13 on, Monday, July 22nd, 2024
- Yasmeen Rahimi of "Piper Sandler" Initiated at Buy and Held Target at $30 on, Thursday, June 13th, 2024
